<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41284139</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1539-0829</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Current diabetes reports</Title><ISOAbbreviation>Curr Diab Rep</ISOAbbreviation></Journal><ArticleTitle>Implementation Components of Diabetes Prevention Programs after Gestational Diabetes Mellitus: A Scoping Review.</ArticleTitle><Pagination><StartPage>58</StartPage><MedlinePgn>58</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11892-025-01615-0</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">To synthesize the components of diabetes prevention programs (DPPs) after gestational diabetes mellitus (GDM) and how they relate to factors that influence implementation. We conducted a scoping review of the literature using MEDLINE, Embase, PsychINFO, and Emcare. We provided a narrative description of intervention components based on the Template for Intervention Description and Replication (TIDieR) and the study results based on the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Seventeen included studies described DPPs after GDM. Recruitment typically began during pregnancy, while interventions started postpartum, with higher reach and participation rates for studies that recruited during pregnancy. The included DPPs used face-to-face delivery, virtual delivery, or a combination. Many programs were individual, but a few had a group component. Program duration varied from one month to three years. The available data highlighted the need to increase engagement, particularly for minority groups, and utilize flexibility and tailoring of program components and delivery to optimize retention, impact and sustainability. Significant barriers to the successful implementation of DPPs after GDM exist; the reporting of intervention components and implementation outcomes in the existing studies is variable. Validated frameworks, including RE-AIM, should be integrated into intervention development, implementation and evaluation.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sushko</LastName><ForeName>Katelyn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8530-6900</Identifier><AffiliationInfo><Affiliation>Women's College Research and Innovation Institute, Women's College Hospital, Toronto, ON, Canada. katelyn.sushko@wchospital.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Racey</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Nursing, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alliston</LastName><ForeName>Paige</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Nursing, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherifali</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Nursing, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Michael Garron Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipscombe</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Women's College Research and Innovation Institute, Women's College Hospital, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>grant number 02432 - 000</GrantID><Agency>Transforming Health with Integrated Care (THINC) Implementation Science Team Grant - Health Services and Policy pool Program: In Partnership with the Canadian Institute of Health Research (CIHR) - Institute of Health Services and Policy Research (IHSPR); CIHR - IMHA; CIHR - SPOR</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000098583">Scoping Review</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Diab Rep</MedlineTA><NlmUniqueID>101093791</NlmUniqueID><ISSNLinking>1534-4827</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016640" MajorTopicYN="Y">Diabetes, Gestational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword><Keyword MajorTopicYN="N">Type 2 diabetes</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: DS has received research support from the Heather M. Arthur Population Health Research Institute/Hamilton Health Sciences Chair in Inter-Professional Health Research. KeS has received research support from the Agency for Healthcare Research and Quality, CIHR, Social Sciences and Humanities Research Council of Canada, Health Quality British Columbia, and Health Insurance Reciprocal of Canada. LL has received research support from CIHR. Human and animal rights and informed consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Disclaimer: The funder/sponsor did not participate in the work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>18</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41284139</ArticleId><ArticleId IdType="doi">10.1007/s11892-025-01615-0</ArticleId><ArticleId IdType="pii">10.1007/s11892-025-01615-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2021 Diabetes Collaborators. Global, regional, and National burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet. 2023;402(10397):203&#x2013;34. https://doi.org/10.1016/S0140-6736(23)01301-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01301-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory EC, Ely DM. Trends and characteristics in gestational diabetes: united States, 2016&#x2013;2020. Natl Vital Stat Rep. 2022;71(3):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">36409968</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt HA, Booth GL, Fazli G, et al. Rising prevalence of gestational diabetes mellitus in Ontario: a population-based study. Can J Diabetes. 2024;48(8):539&#x2013;43. https://doi.org/10.1016/j.jcjd.2024.10.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjd.2024.10.001</ArticleId><ArticleId IdType="pubmed">39414118</ArticleId></ArticleIdList></Reference><Reference><Citation>Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Ramezani Tehrani F. The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol Metab Syndr. 2019;11:11. https://doi.org/10.1186/s13098-019-0406-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-019-0406-1</ArticleId><ArticleId IdType="pubmed">30733833</ArticleId><ArticleId IdType="pmc">6359830</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8(11):639&#x2013;49. https://doi.org/10.1038/nrendo.2012.96 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2012.96</ArticleId><ArticleId IdType="pubmed">22751341</ArticleId><ArticleId IdType="pmc">4404707</ArticleId></ArticleIdList></Reference><Reference><Citation>Noctor E, Dunne FP. Type 2 diabetes after gestational diabetes: the influence of changing diagnostic criteria. World J Diabetes. 2015;6(2):234&#x2013;44. https://doi.org/10.4239/wjd.v6.i2.234 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4239/wjd.v6.i2.234</ArticleId><ArticleId IdType="pubmed">25789105</ArticleId><ArticleId IdType="pmc">4360417</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Santana MV, O&#x2019;Brien KM, Park YM, Sandler DP, Weinberg CR. Persistence of risk for type 2 diabetes after gestational diabetes mellitus. Diabetes Care. 2022;45(4):864&#x2013;70. https://doi.org/10.2337/dc21-1430 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1430</ArticleId><ArticleId IdType="pubmed">35104325</ArticleId><ArticleId IdType="pmc">9016728</ArticleId></ArticleIdList></Reference><Reference><Citation>Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the type 2 diabetes mellitus. Curr Cardiol Rev. 2020;16(4):249&#x2013;51. https://doi.org/10.2174/1573403X1604201229115531 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573403X1604201229115531</ArticleId><ArticleId IdType="pubmed">33407062</ArticleId><ArticleId IdType="pmc">7903505</ArticleId></ArticleIdList></Reference><Reference><Citation>Salzberg L. Risk factors and lifestyle interventions. Prim Care. 2022;49(2):201&#x2013;12. https://doi.org/10.1016/j.pop.2021.11.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pop.2021.11.001</ArticleId><ArticleId IdType="pubmed">35595477</ArticleId></ArticleIdList></Reference><Reference><Citation>Aroda VR, Christophi CA, Edelstein SL, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646&#x2013;53. https://doi.org/10.1210/jc.2014-3761 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2014-3761</ArticleId><ArticleId IdType="pubmed">25706240</ArticleId><ArticleId IdType="pmc">4399293</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennison RA, Ward RJ, Griffin SJ, Usher-Smith JA. Women&#x2019;s views on lifestyle changes to reduce the risk of developing Type 2 diabetes after gestational diabetes: a systematic review, qualitative synthesis and recommendations for practice. Diabet Med. 2019;36(6):702&#x2013;17. https://doi.org/10.1111/dme.13926 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dme.13926</ArticleId><ArticleId IdType="pubmed">30723968</ArticleId><ArticleId IdType="pmc">6563496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EJ, Fraley HE, Mazzawi J. Appreciating recent motherhood and culture: a systematic review of multimodal postpartum lifestyle interventions to reduce diabetes risk in women with prior gestational diabetes. Matern Child Health J. 2017;21(1):45&#x2013;57. https://doi.org/10.1007/s10995-016-2092-z .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10995-016-2092-z</ArticleId><ArticleId IdType="pubmed">27435732</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento SL, Pudwell J, Surita FG, Adamo KB, Smith GN. The effect of physical exercise strategies on weight loss in postpartum women: a systematic review and meta-analysis. Int J Obes (Lond). 2014;38(5):626&#x2013;35. https://doi.org/10.1038/ijo.2013.183 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2013.183</ArticleId><ArticleId IdType="pubmed">24048142</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Magny-Normilus C, McMahon E, Whittemore R. Systematic review of lifestyle interventions for gestational diabetes mellitus in pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 2022;51(2):115&#x2013;25. https://doi.org/10.1016/j.jogn.2021.10.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jogn.2021.10.007</ArticleId><ArticleId IdType="pubmed">34843670</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedeager Momsen AM, Hotoft D, Ortenblad L, et al. Diabetes prevention interventions for women after gestational diabetes mellitus: an overview of reviews. Endocrinol Diabetes Metab. 2021;4(3):e00230. https://doi.org/10.1002/edm2.230 . Published 2021 Feb 1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/edm2.230</ArticleId><ArticleId IdType="pubmed">34277958</ArticleId><ArticleId IdType="pmc">8279604</ArticleId></ArticleIdList></Reference><Reference><Citation>H TC, G PP, B I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. https://doi.org/10.1136/bmj.g1687 . Published 2014 Mar 7.</Citation></Reference><Reference><Citation>Glowgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89(9):1322&#x2013;7. https://doi.org/10.2105/ajph.89.9.1322 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/ajph.89.9.1322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sushko K, Sherifali D, Smith K, Lipscombe LL. Mapping the components of the effective implementation of diabetes prevention programmes after gestational diabetes mellitus: a protocol for a scoping review. BMJ Open. 2025;15(5):e088811. https://doi.org/10.1136/bmjopen-2024-088811 . Published 2025 May 6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2024-088811</ArticleId><ArticleId IdType="pubmed">40328652</ArticleId><ArticleId IdType="pmc">12056632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottlieb M, Haas MRC, Daniel M, Chan TM. The scoping review: a flexible, inclusive, and iterative approach to knowledge synthesis. AEM Educ Train. 2021;5(3):e10609. https://doi.org/10.1002/aet2.10609 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aet2.10609</ArticleId><ArticleId IdType="pubmed">34222749</ArticleId><ArticleId IdType="pmc">8237090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arksey H, O&#x2019;Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8:19&#x2013;32. https://doi.org/10.1080/1364557032000119616 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1364557032000119616</ArticleId></ArticleIdList></Reference><Reference><Citation>Levac D, Colquhoun H, O&#x2019;Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:1&#x2013;9. https://doi.org/10.1186/1748-5908-5-69 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-5-69</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467&#x2013;73. https://doi.org/10.7326/M18-0850 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009;62(9):944&#x2013;52. https://doi.org/10.1016/j.jclinepi.2008.10.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2008.10.012</ArticleId><ArticleId IdType="pubmed">19230612</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40&#x2013;6. https://doi.org/10.1016/j.jclinepi.2016.01.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.01.021</ArticleId><ArticleId IdType="pubmed">27005575</ArticleId></ArticleIdList></Reference><Reference><Citation>McGowan et al. November. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Explanation and Elaboration (PRESS E&amp;E). January 2016. Retrieved on 10 2025 from: https://www.cda-amc.ca/sites/default/files/pdf/CP0015_PRESS_Update_Report_2016.pdf</Citation></Reference><Reference><Citation>Knudsen LL, Knorr S, Prange SK, et al. Clinical and metabolic characterization of women with gestational diabetes mellitus within the first year postpartum. J Endocr Soc. 2024;8(6):bvae044. https://doi.org/10.1210/jendso/bvae044 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvae044</ArticleId><ArticleId IdType="pubmed">38601785</ArticleId><ArticleId IdType="pmc">11004785</ArticleId></ArticleIdList></Reference><Reference><Citation>Minschart C, Myngheer N, Maes T, et al. Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial. EClinicalMedicine. 2024;70:102523. https://doi.org/10.1016/j.eclinm.2024.102523 . Published 2024 Mar 8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102523</ArticleId><ArticleId IdType="pubmed">38495521</ArticleId><ArticleId IdType="pmc">10940944</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn CE, Seely EW, Levkoff SE, Isley BC, Nicklas JM. Postpartum women&#x2019;s experiences in a randomized controlled trial of a web-based lifestyle intervention following Gestational Diabetes: a qualitative study. J Matern Fetal Neonatal Med. 2023;36(1):2194012. https://doi.org/10.1080/14767058.2023.2194012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2023.2194012</ArticleId><ArticleId IdType="pubmed">36977603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandon N, Gupta Y, Kapoor D, et al. Effects of a lifestyle intervention to prevent deterioration in glycemic status among South Asian women with recent gestational diabetes: a randomized clinical trial. JAMA Netw Open. 2022;5(3):e220773. https://doi.org/10.1001/jamanetworkopen.2022.0773 . (Published 2022 Mar 1).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.0773</ArticleId><ArticleId IdType="pubmed">35234881</ArticleId><ArticleId IdType="pmc">8892226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KW, Tan SF, Omar A, et al. Effectiveness of system-based intervention in reducing incidence of type 2 diabetes and to improve the postnatal metabolic profiles in women with gestational diabetes mellitus: a randomized controlled study. Gynecol Endocrinol. 2022;38(1):55&#x2013;62. https://doi.org/10.1080/09513590.2021.1988561 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09513590.2021.1988561</ArticleId><ArticleId IdType="pubmed">34636710</ArticleId></ArticleIdList></Reference><Reference><Citation>Huvinen E, Koivusalo SB, Meinil&#xe4; J, et al. Effects of a lifestyle intervention during pregnancy and first postpartum year: findings from the RADIEL study. J Clin Endocrinol Metab. 2018;103(4):1669&#x2013;77. https://doi.org/10.1210/jc.2017-02477 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2017-02477</ArticleId><ArticleId IdType="pubmed">29409025</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes VA, Draffin CR, Patterson CC, et al. Postnatal lifestyle intervention for overweight women with previous gestational diabetes: a randomized controlled trial. J Clin Endocrinol Metab. 2018;103(7):2478&#x2013;87. https://doi.org/10.1210/jc.2017-02654 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2017-02654</ArticleId><ArticleId IdType="pubmed">29762737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara A, Hedderson MM, Brown SD, et al. The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the gestational diabetes&#x2019; effects on moms (GEM) cluster randomized controlled trial. Diabetes Care. 2016;39(1):65&#x2013;74. https://doi.org/10.2337/dc15-1254 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-1254</ArticleId><ArticleId IdType="pubmed">26657945</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly SL, Dunbar JA, Versace V, et al. Mothers after gestational diabetes in Australia (MAGDA): a randomised controlled trial of a postnatal diabetes prevention program. PLoS Med. 2016;13(7):e1002092. https://doi.org/10.1371/journal.pmed.1002092 . (Published 2016 Jul 26).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002092</ArticleId><ArticleId IdType="pubmed">27459502</ArticleId><ArticleId IdType="pmc">4961439</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Ferre N, Del Valle L, Torrej&#xf3;n MJ, et al. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: a three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups. Clin Nutr. 2015;34(4):579&#x2013;85. https://doi.org/10.1016/j.clnu.2014.09.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2014.09.005</ArticleId><ArticleId IdType="pubmed">25262459</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dea A, Tierney M, McGuire BE, et al. Can the onset of type 2 diabetes be delayed by a Group-Based lifestyle intervention in women with prediabetes following gestational diabetes mellitus (GDM)? Findings from a randomized control mixed methods trial. J Diabetes Res. 2015;2015:798460. https://doi.org/10.1155/2015/798460 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/798460</ArticleId><ArticleId IdType="pubmed">26347894</ArticleId><ArticleId IdType="pmc">4546980</ArticleId></ArticleIdList></Reference><Reference><Citation>Shek NW, Ngai CS, Lee CP, Chan JY, Lao TT. Lifestyle modifications in the development of diabetes mellitus and metabolic syndrome in Chinese women who had gestational diabetes mellitus: a randomized interventional trial. Arch Gynecol Obstet. 2014;289(2):319&#x2013;27. https://doi.org/10.1007/s00404-013-2971-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-013-2971-0</ArticleId><ArticleId IdType="pubmed">23897066</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MEM, Edwards CV, Athavale P, et al. The STAR-MAMA RCT: bilingual mobile health coaching for postpartum weight loss. Am J Prev Med. 2023;65(4):596&#x2013;607. https://doi.org/10.1016/j.amepre.2023.03.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2023.03.021</ArticleId><ArticleId IdType="pubmed">37028566</ArticleId><ArticleId IdType="pmc">11505129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedderson MM, Brown SD, Ehrlich SF, et al. A tailored letter based on electronic health record data improves gestational weight gain among women with gestational diabetes mellitus: the gestational diabetes&#x2019; effects on moms (GEM) cluster-randomized controlled trial. Diabetes Care. 2018;41(7):1370&#x2013;7. https://doi.org/10.2337/dc17-1133 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-1133</ArticleId><ArticleId IdType="pubmed">29669736</ArticleId><ArticleId IdType="pmc">6463614</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus R, Miller D, Mottola M, Giroux I, Donovan L. Translating healthy living messages to postpartum women and their partners after gestational diabetes (GDM): body habitus, A1C, lifestyle habits, and program engagement results from the families defeating diabetes (FDD) randomized trial. Am J Health Promot. 2018;32(6):1438&#x2013;46. https://doi.org/10.1177/0890117117738210 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0890117117738210</ArticleId><ArticleId IdType="pubmed">29108443</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock AS, Bogossian FE, Wilkinson SA, Gibbons KS, Kim C, McIntyre HD. A randomised controlled trial to delay or prevent type 2 diabetes after gestational diabetes: walking for exercise and nutrition to prevent diabetes for you. Int J Endocrinol. 2015;2015:423717. https://doi.org/10.1155/2015/423717 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/423717</ArticleId><ArticleId IdType="pubmed">26089886</ArticleId><ArticleId IdType="pmc">4452189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Kravits D, Meyerstein N, Abu-Rabia Y, Wiznitzer A, Harman-Boehm I. The impact of a cultural lifestyle intervention on metabolic parameters after gestational diabetes mellitus a randomized controlled trial. Matern Child Health J. 2018;22(6):803&#x2013;11. https://doi.org/10.1007/s10995-018-2450-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10995-018-2450-0</ArticleId><ArticleId IdType="pubmed">29411251</ArticleId></ArticleIdList></Reference><Reference><Citation>ACOG Committee Opinion No. 736: optimizing postpartum care. Obstet Gynecol. 2018;131(5):e140&#x2013;50. https://doi.org/10.1097/AOG.0000000000002633 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000002633</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig MD, Tussing-Hymphreys L, DeMartelly V, et al. Recruitment and retention of urban pregnant women to a clinical study administering an oral isotope dietary tracer. Womens Health Rep (New Rochelle). 2022;3(1):652&#x2013;60. https://doi.org/10.1089/whr.2022.0015 . Published 2022 Jul 18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/whr.2022.0015</ArticleId><ArticleId IdType="pubmed">35982776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulme K, Chilcot J, Smith MA. Doctor-patient relationship and quality of life in irritable bowel syndrome: an exploratory study of the potential mediating role of illness perceptions and acceptance. Psychol Health Med. 2018;23(6):674&#x2013;84. https://doi.org/10.1080/13548506.2017.1417613 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13548506.2017.1417613</ArticleId><ArticleId IdType="pubmed">29260889</ArticleId></ArticleIdList></Reference><Reference><Citation>The Virtual Care Task Force. Virtual Care in Canada: Progress and Potential. 2022. Retrieved from: https://www.cma.ca/sites/default/files/2022-02/Virtual-Care-in-Canada-Progress-and-Potential-EN.pdf</Citation></Reference><Reference><Citation>Oxlad M, Whitburn S, Grieger JA. The complexities of managing gestational diabetes in women of culturally and linguistically diverse backgrounds: a qualitative study of women&#x2019;s experiences. Nutrients. 2023;15(4):1053. https://doi.org/10.3390/nu15041053 . (Published 2023 Feb 20).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15041053</ArticleId><ArticleId IdType="pubmed">36839411</ArticleId><ArticleId IdType="pmc">9967365</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadi NM, Asantewa-Ampaduh S, Rivas C, Goff LM. Culturally tailored lifestyle interventions for the prevention and management of type 2 diabetes in adults of black African ancestry: a systematic review of tailoring methods and their effectiveness. Public Health Nutr. 2022;25(2):422&#x2013;36. https://doi.org/10.1017/S1368980021003682 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1368980021003682</ArticleId><ArticleId IdType="pubmed">34435943</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo JY, Liu MF. Culturally tailored interventions for ethnic minorities: a scoping review. Nurs Open. 2021;8(5):2078&#x2013;90. https://doi.org/10.1002/nop2.733 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nop2.733</ArticleId><ArticleId IdType="pubmed">34388862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalali MS, Rahmandad H, Bullock SL, Lee-Kwan SH, Gittelsohn J, Ammerman A. Dynamics of intervention adoption, implementation, and maintenance inside organizations: the case of an obesity prevention initiative. Soc Sci Med. 2019;224:67&#x2013;76. https://doi.org/10.1016/j.socscimed.2018.12.021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2018.12.021</ArticleId><ArticleId IdType="pubmed">30763824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41282747</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Gestational Diabetes - Risk Factors and Outcomes among American Samoan Women (GROW): A Longitudinal Cohort Study Protocol.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2025.10.24.25338761</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2025.10.24.25338761</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Gestational diabetes mellitus (GDM) is linked with adverse health outcomes for both mother and infant and increases the risk of type 2 diabetes mellitus (T2DM) and long-term metabolic dysfunction postpartum. American Samoa experiences among the highest prevalence of GDM globally, with estimates suggesting 26-42% of women develop the condition. To date, no studies have attempted to understand the underlying etiology of GDM in Pacific Islanders or examine population-specific progression from GDM to T2DM. The GROW study will characterize glucose homeostasis, diabetes progression, and the impact of a Pacific-specific variant (rs373863828) in the <i>CREBRF</i> gene, which is known to protect against T2DM, on glucose metabolism during and after pregnancy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We will establish a prospective cohort study of 350 pregnant women in American Samoa, enrolled in their first trimester and followed through 18 months postpartum. Participants will be genotyped for <i>CREBRF</i> rs373863828 and undergo frequently-sampled oral glucose tolerance test (fs-OGTTs), glycated hemoglobin (HbA1c), and continuous glucose monitoring (CGM) measurements to identify glycemic patterns across the perinatal period. Participants will complete questionnaires assessing reproductive health history, diet, physical activity, sleep, and psychosocial health. We will examine associations between <i>CREBRF</i> genotype and glucose homeostasis across pregnancy and postpartum and evaluate risk of GDM and subsequent T2DM. We will also explore associations between <i>CREBRF</i> genotype, changes in insulin secretion in pregnancy, and risk of adverse birth outcomes.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Findings from this study are expected to inform precision medicine approaches to diabetes prevention, refine public health policies and clinical guidelines, and support community-based interventions aimed at reducing GDM and T2DM among Pacific Islander women and more broadly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carson</LastName><ForeName>Danielle J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Faasalele-Savusa</LastName><ForeName>Kima</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Loia</LastName><ForeName>Miracle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tasele</LastName><ForeName>Susie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Iosefa</LastName><ForeName>Emele</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Tupuola</LastName><ForeName>Peresia</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Kelly C</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Kaabi</LastName><ForeName>Oumaima</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Valencia</LastName><ForeName>Rachel K</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Rossillo</LastName><ForeName>Mary G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Murthy</LastName><ForeName>Neharika</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Akinade</LastName><ForeName>Tolulope</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Heinsberg</LastName><ForeName>Lacey W</ForeName><Initials>LW</Initials><Identifier Source="ORCID">0000-0002-7690-5485</Identifier></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>Jenna C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0001-5483-0833</Identifier></Author><Author ValidYN="Y"><LastName>Flannery</LastName><ForeName>Clare A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>McGarvey</LastName><ForeName>Stephen T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Ashlee N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Anesi</LastName><ForeName>Scott</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tofaeono</LastName><ForeName>Va'atausili</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Desobry</LastName><ForeName>Katie</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Muasau-Howard</LastName><ForeName>Bethel T</ForeName><Initials>BT</Initials></Author><Author ValidYN="Y"><LastName>Bengtson</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Kershaw</LastName><ForeName>Erin E</ForeName><Initials>EE</Initials></Author><Author ValidYN="Y"><LastName>Hawley</LastName><ForeName>Nicola L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0002-2601-3454</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>24</Day><Hour>9</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41282747</ArticleId><ArticleId IdType="pmc">PMC12636633</ArticleId><ArticleId IdType="doi">10.1101/2025.10.24.25338761</ArticleId><ArticleId IdType="pii">2025.10.24.25338761</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41269698</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-1539</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>American journal of physiology. Heart and circulatory physiology</Title><ISOAbbreviation>Am J Physiol Heart Circ Physiol</ISOAbbreviation></Journal><ArticleTitle>Human fetal circulating factors from pregnancies complicated by obesity upregulate genes associated with pathological hypertrophy in neonatal rat cardiomyocytes.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1152/ajpheart.00375.2025</ELocationID><Abstract><AbstractText>Obesity in pregnant women increases offspring cardiovascular risk and causes fetal cardiac dysfunction. The underpinning mechanisms remain unclear. We hypothesised that circulating factors in serum from fetuses of women with obesity induce pathological cardiomyocyte hypertrophy. Pregnant women with obesity or healthy weight were recruited at term and provided umbilical cord serum and placentas, which were used for isolation of primary trophoblast cells. Primary cardiomyocytes were isolated from neonatal rats. Compared to cord serum from healthy weight women, cord serum from women with obesity upregulated cardiomyocyte mRNA expression of atrial natriuretic factor (<i>Anf</i>) and brain natriuretic peptide (<i>Bnp</i>) and increased the ratio of beta- to alpha-myosin heavy chain expression (<i>Myh7:Myh6</i>), when it was supplemented into the culture medium. This effect was prevented by treating the cord serum with heat-freeze cycling and DNase or RNase digestion. Separately, conditioned medium from trophoblast cells from women with obesity increased cardiomyocyte <i>Anf</i> expression without altering <i>Bnp</i> or <i>Myh7:Myh6</i>. MicroRNAs miR-142 and miR-17, which are associated with cardiac function, were increased in abundance in extracellular vesicles isolated from cord serum from women with obesity. However, miR-142-3p, miR-142-5p and miR-17-5p did not increase <i>Anf</i>, <i>Bnp</i> or <i>Myh7:Myh6</i> expression when they were transfected into cardiomyocytes. Neither cord serum nor the upregulated microRNAs from women with obesity altered cardiomyocyte size. The results show that human fetal circulating and placenta-derived factors induce gene expression hallmarks of pathological hypertrophy in cardiomyocytes and may mediate cardiac dysfunction in children of women with obesity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vaughan</LastName><ForeName>Owen R</ForeName><Initials>OR</Initials><Identifier Source="ORCID">0000-0001-7537-3264</Identifier><AffiliationInfo><Affiliation>Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Maternal and Fetal Medicine, EGA Institute for Women's Health, University College London, 86-98 Chenies Mews, London, WC1E 6HX, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodspeed</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sucharov</LastName><ForeName>Carmen C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0003-0349-1776</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell</LastName><ForeName>Theresa L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jansson</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8123-9480</Identifier><AffiliationInfo><Affiliation>Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CU | Center for Women's Health Research, University of Colorado (CWHR, UC)</Agency><Country/></Grant><Grant><GrantID>R01HD065007</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>P30DK048520</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>P30CA046934</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>MR/W028301/1</GrantID><Agency>UKRI | Medical Research Council (MRC)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Physiol Heart Circ Physiol</MedlineTA><NlmUniqueID>100901228</NlmUniqueID><ISSNLinking>0363-6135</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiomyopathy, hypertrophic</Keyword><Keyword MajorTopicYN="N">diabetes, gestational</Keyword><Keyword MajorTopicYN="N">exosomes</Keyword><Keyword MajorTopicYN="N">fetal organ maturity</Keyword><Keyword MajorTopicYN="N">metabolic syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41269698</ArticleId><ArticleId IdType="doi">10.1152/ajpheart.00375.2025</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41267556</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-7270</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Acta biochimica et biophysica Sinica</Title><ISOAbbreviation>Acta Biochim Biophys Sin (Shanghai)</ISOAbbreviation></Journal><ArticleTitle>Pregnancy-induced metabolic reprogramming in skeletal muscle: a multi-omics interrogation of transcriptional and metabolic adaptations.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3724/abbs.2025199</ELocationID><Abstract><AbstractText>Pregnancy induces profound physiological adaptations to meet the dynamic nutritional demands of fetal development, including a deliberate reduction in maternal insulin sensitivity to ensure fetal glucose availability. However, excessive insulin resistance may precipitate gestational diabetes mellitus (GDM), increasing the risk of both obstetric complications and long-term metabolic disorders in mothers and offspring. Although the role of adipose tissue in pregnancy-associated metabolic adaptation has been extensively studied, the contribution of skeletal muscle remains poorly understood. Here, we systematically characterize pregnancy-induced molecular and metabolic changes in maternal skeletal muscle through multi-omics profiling. We use transcriptomic, metabolomic, computational single-cell deconvolution, and qPCR validation in an established C57BL/6J mouse pregnancy model (8-week-old females). Pregnancy triggers remarkable skeletal muscle remodelling, featuring histological reorganization with myofiber depletion and expanded endothelial compartments. Concurrent metabolic disturbances include insulin resistance, dysregulated TCA cycle activity, and impaired ubiquinone biosynthesis. This study represents a multi-omics-based systematic elucidation of pregnancy-induced maternal skeletal muscle adaptations. Our findings demonstrate that pregnancy induces profound structural reorganization and metabolic reprogramming in maternal skeletal muscle, characterized by prioritized fetal nutrient provision at the expense of maternal tissue utilization. These observations not only reveal previously unrecognized mechanisms of pregnancy-specific metabolic regulation but also, more importantly, establish a critical theoretical foundation for developing skeletal muscle-targeted intervention strategies to prevent gestational diabetes mellitus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Zhongliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Kejing</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Renke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xueying</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Qinyu</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Jianzhong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jiexue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Hefeng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Genetics and Development, Key Laboratory of Reproductive Genetics (Ministry of Education), Department of Reproductive Endocrinology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310058, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Center for Reproductive Medicine, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322099, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Reproduction and Development, Shanghai Key Laboratory of Reproduction and Development, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Acta Biochim Biophys Sin (Shanghai)</MedlineTA><NlmUniqueID>101206716</NlmUniqueID><ISSNLinking>1672-9145</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">metabolic adaptation</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">skeletal muscle</Keyword><Keyword MajorTopicYN="N">transcriptomic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>3</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41267556</ArticleId><ArticleId IdType="doi">10.3724/abbs.2025199</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41267065</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>20</Day></PubDate></JournalIssue><Title>BMC pregnancy and childbirth</Title><ISOAbbreviation>BMC Pregnancy Childbirth</ISOAbbreviation></Journal><ArticleTitle>Prognostic value of antepartum LDH serum levels in predicting adverse maternal outcomes in hypertensive disorders of pregnancy: a prospective cohort study.</ArticleTitle><Pagination><StartPage>1249</StartPage><MedlinePgn>1249</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1249</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12884-025-08293-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal mortality, particularly in low-resource settings. While lactate dehydrogenase (LDH) has been proposed as a prognostic biomarker, its clinical utility is limited by a lack of consensus on a standardized threshold for interpretation. This study aimed to evaluate the predictive performance of antenatal LDH for adverse maternal outcomes and establish a clinically applicable cutoff for risk stratification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective cohort study included 336 pregnant women with HDP admitted to a national tertiary referral hospital in Vietnam. Serum LDH levels were measured before delivery, and treating clinicians were blinded to the results to prevent performance bias. The primary outcome was a composite of adverse maternal events: eclampsia, HELLP syndrome, placental abruption, acute kidney injury, hepatic injury, pulmonary edema, and maternal death. Multivariate logistic regression and receiver operating characteristic curve analysis were performed to assess associations and predictive performance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">As a single predictor, LDH demonstrated good overall discrimination for adverse maternal outcomes (AUC&#x2009;=&#x2009;0.793). In a multivariable logistic regression model, adjusting for proteinuria, highest diastolic blood pressure (DBP), highest systolic blood pressure (SBP), urea, creatinine, maternal age, gravidity, body mass index (BMI), platelets, gestational diabetes mellitus, an LDH level&#x2009;&#x2265;&#x2009;254.7 U/L remained a strong and independent predictor of the primary outcome (aOR 9.67; 95% CI 3.29-28.46). Notably, in this high-risk cohort, traditional factors like proteinuria and maternal age were not significant independent predictors in this adjusted model. The multivariable model demonstrated strong internal validity, with all the predictors having a variance inflation factor (VIF)&#x2009;&lt;&#x2009;5, indicating an absence of multicollinearity and, therefore, stable regression estimates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Antepartum LDH level&#x2009;&#x2265;&#x2009;254.7 U/L is a strong, independent predictor of adverse maternal outcomes in patients with HDP. These findings, combined with the test's affordability and accessibility, underscore the potential of LDH as a valuable tool for improving risk stratification, particularly in low-resource settings.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thang</LastName><ForeName>Nguyen Manh</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Hospital of Obstetrics and Gynecology, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ky</LastName><ForeName>Nguyen Dinh</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huong</LastName><ForeName>Truong Thanh</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Phenikaa University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anh</LastName><ForeName>Nguyen Quynh</ForeName><Initials>NQ</Initials><AffiliationInfo><Affiliation>Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>My</LastName><ForeName>Nguyen Dieu</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anh</LastName><ForeName>Nguyen Thi Huyen</ForeName><Initials>NTH</Initials><Identifier Source="ORCID">0000-0002-3087-8063</Identifier><AffiliationInfo><Affiliation>Hanoi Medical University, Hanoi, Vietnam. nguyenthihuyenanh@hmu.edu.vn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Hospital of Obstetrics and Gynecology, Hanoi, Vietnam. nguyenthihuyenanh@hmu.edu.vn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pregnancy Childbirth</MedlineTA><NlmUniqueID>100967799</NlmUniqueID><ISSNLinking>1471-2393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.1.1.27</RegistryNumber><NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007770" MajorTopicYN="Y">L-Lactate Dehydrogenase</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046110" MajorTopicYN="Y">Hypertension, Pregnancy-Induced</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014744" MajorTopicYN="N" Type="Geographic">Vietnam</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017359" MajorTopicYN="N">HELLP Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008428" MajorTopicYN="N">Maternal Mortality</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse maternal outcomes</Keyword><Keyword MajorTopicYN="N">Hypertensive disorders of pregnancy</Keyword><Keyword MajorTopicYN="N">LDH</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The study was conducted by the principles of the Declaration of Helsinki. Ethical approval was obtained from the Institutional Review Board for Ethics in Biomedical Research. (Approval Number: 820/GCN-H&#x110;&#x110;&#x110;NCYSH-&#x110;HYHN). All study participants received a detailed explanation of the study. They provided written informed consent before the study commenced, underscoring the study&#x2019;s adherence to ethical standards. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>21</Day><Hour>0</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>11</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41267065</ArticleId><ArticleId IdType="pmc">PMC12632058</ArticleId><ArticleId IdType="doi">10.1186/s12884-025-08293-6</ArticleId><ArticleId IdType="pii">10.1186/s12884-025-08293-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hypertension in Pregnancy. Exec Summary Obstet Gynecol. 2013;122(5):1122.</Citation><ArticleIdList><ArticleId IdType="pubmed">24150027</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar MF, Benitez-D&#xed;az N, Blanco-Londo&#xf1;o I, Cer&#xf3;n-Garc&#xe9;s C, Pe&#xf1;a-Z&#xe1;rate EE, Guevara-Calder&#xf3;n LA, et al. Synthesis of evidence for managing hypertensive disorders of pregnancy in low- and middle-income countries: a scoping review. BMC Pregnancy Childbirth. 2024;24(1):622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11443752</ArticleId><ArticleId IdType="pubmed">39354425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukah UV, Payne B, Karjalainen H, Kortelainen E, Seed PT, Conti-Ramsden FI, et al. Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with preeclampsia. Pregnancy Hypertens. 2019;15:42&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">30825926</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the minipiers (Preeclampsia integrated estimate of risk) multi-country prospective cohort study. PLoS Med. 2014;11(1):e1001589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3897359</ArticleId><ArticleId IdType="pubmed">24465185</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifai N, editor. Tietz Textbook of Laboratory Medicine. 7th ed. Philadelphia: Saunders; 2022. Section III: Clinical Chemistry &#x2013; Analytes. Chapter 32: Serum Enzymes.</Citation></Reference><Reference><Citation>Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia. Pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094&#x2013;112. 10.1161/CIRCRESAHA.118.313276.</Citation><ArticleIdList><ArticleId IdType="pubmed">30920918</ArticleId></ArticleIdList></Reference><Reference><Citation>Moharana JJ, Mishra R, Nayak AK. A study on serum lactate dehydrogenase and uric acid in preeclampsia and eclampsia: can they predict adverse fetomaternal outcome? Int J Appl Basic Med Res. 2023;13(2):95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10443457</ArticleId><ArticleId IdType="pubmed">37614835</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir SK, Khalil RY, Mahmood MB, Dawd AS. Serum lactate dehydrogenase level in preeclampsia and its correlation with disease severity, maternal and perinatal outcomes. BMC Womens Health. 2025;25(1):108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11892178</ArticleId><ArticleId IdType="pubmed">40065292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gestational Hypertension and Preeclampsia. ACOG practice Bulletin, number 222. Obstet Gynecol. 2020;135(6):e237.</Citation><ArticleIdList><ArticleId IdType="pubmed">32443079</ArticleId></ArticleIdList></Reference><Reference><Citation>Millman AL, Payne B, Qu Z, Joanne Douglas M, Hutcheon JA, Lee T, et al. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2011;33(7):705&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">21749746</ArticleId></ArticleIdList></Reference><Reference><Citation>Teklemariam AB, Abebe EC, Agidew MM, Ayenew AA, Mengistie MA, Baye ND, Muche ZT. Diagnostic performance of lactate dehydrogenase as a potential biomarker in predicting preeclampsia and associated factors. Front Med (Lausanne). 2024;11:1240848. 10.3389/fmed2024.1240848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11116690</ArticleId><ArticleId IdType="pubmed">38799154</ArticleId></ArticleIdList></Reference><Reference><Citation>Burwick RM, Rincon M, Beeraka SS, Gupta M, Feinberg BB. Evaluation of hemolysis as a severe feature of preeclampsia. Hypertension. 2018;72(2):460&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">29941517</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y, Liu J, Wang Y, Hu J, Chen S, Li J, et al. Development and validation of nomograms to predict clinical outcomes of preeclampsia. Front Endocrinol (Lausanne). 2024;15:1292458. 10.3389/fendo.2024.1292458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10972945</ArticleId><ArticleId IdType="pubmed">38549768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen KD, Khuc ATN, Tran VA, Nguyen HS, Nguyen PH, Nguyen ATH. Antepartum serum lactate dehydrogenase and adverse obstetric outcomes in preeclampsia: a systematic review of prognostic evidence from low- and middle-income countries. Cureus. 2025;17(6):e86496. 10.7759/cureus. 86496. PMID: 40548151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12182434</ArticleId><ArticleId IdType="pubmed">40548151</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev SV, Hemalatha CR. Evaluation of maternal and perinatal outcomes in preeclampsia and eclampsia in correlation with LDH. Indian Journal of Obstetrics and Gynecology Research. 2019;6(4):499&#x2013;503.</Citation></Reference><Reference><Citation>Dave A, Maru L, Jain A. LDH (Lactate dehydrogenase): a biochemical marker for the prediction of adverse outcomes in preeclampsia and eclampsia. J Obstet Gynaecol India. 2016;66(1):23&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755940</ArticleId><ArticleId IdType="pubmed">26924903</ArticleId></ArticleIdList></Reference><Reference><Citation>Qublan HS, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I, et al. Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe preeclampsia. Med Sci Monit Int Med J Exp Clin Res. 2005;11(8):CR393&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">16049382</ArticleId></ArticleIdList></Reference><Reference><Citation>Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. a review. BMC Pregnancy Childbirth. 2009;9(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2654858</ArticleId><ArticleId IdType="pubmed">19245695</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY. Hypertensive disorders. Williams obstetrics. 26th ed. New York: McGraw-Hill Medical; 2022. pp. 728&#x2013;78.</Citation></Reference><Reference><Citation>Mol BW, Roberts CT, von Dadelszen P, Magee LA. Preventing preeclampsia and its complications. In: Magee LA, von Dadelszen P, Stones W, Mathai M, editors. The FIGO textbook of pregnancy hypertension: an Evidence-Based guide to Monitoring, prevention and management. London: The Global Library of Women&#x2019;s Medicine (GLOWM); 2016. pp. 101&#x2013;22.</Citation></Reference><Reference><Citation>Dr&#xf6;ge LA, Perschel FH, St&#xfc;tz N, Gafron A, Frank L, Busjahn A, et al. Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) ratio in the clinical routine. Hypertension. 2021;77(2):461&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">33280406</ArticleId></ArticleIdList></Reference><Reference><Citation>von Dadelszen P, Payne B, Li J, Ansermino JM, Pipkin FB, C&#xf4;t&#xe9; AM, et al. Prediction of adverse maternal outcomes in preeclampsia: development and validation of the fullpiers model. Lancet. 2011;377(9761):219&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">21185591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mai TD, Nguyen DT, Pham HS, Nguyen THP, Le LH. Factors associated with indications for Cesarean delivery at the National hospital of obstetrics and gynecology in 2021. Vietnam J Obstet Gynecol. 2022;20(3):46&#x2013;9. 10.46755/vjog.2022.3.1506.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>